Cell-specific MAPT gene expression is preserved in tau cytopathologies in Progressive Supranuclear Palsy
Objective: To systematically map and quantify MAPT expression in neurons, astrocytes and oligodendroglia across different brain regions to determine whether cell type and/or regional differences…Impulse control disorder related to dopaminergic therapy in progressive supranuclear palsy
Objective: To report a patient with progressive supranuclear palsy (PSP) in whom an impulse control disorder (ICD) was triggered by a dopaminergic therapy. Background: ICDs…MRI morphometry and regional hypometabolism in the clinical predominance-types of Progressive Supranuclear Palsy
Objective: To compare brain MRI morphometry and regional hypometabolism among the clinical predominance-types of Progressive Supranuclear Palsy. Background: Recently, MDS-PSP criteria for the clinical diagnosis…TEP-PSP: preliminary results of a therapeutic education program in progressive supranuclear palsy
Objective: To explore the feasibility and satisfaction of a therapeutic education program (TEP) in progressive supranuclear palsy (PSP). Background: PSP is a rare tauopathy with…Corticobasal Syndrome (CBS), Corticobasal Degeneration (CBD) and Progressive Supranuclear Palsy (PSP) Cohort in Central New York
Objective: Aims: The goal of this retrospective study was to characterize a CBS, CBD and PSP cohort and demonstrate that the Electronic Medical Record (EMR)…18F-Florzolotau PET Imaging Captures the Distribution Patterns and Regional Vulnerability of Tau Pathology in Progressive Supranuclear Palsy
Objective: This study aimed to investigate whether 18F-Florzolotau PET imaging may capture the distribution patterns and regional vulnerability of tau pathology in PSP, and to…Tau PET imaging in a patient with progressive supranuclear palsy-parkinsonism-a case report
Objective: Early detection of the brain tau deposition in patients with progressive supranuclear palsy-parkinsonism (PSP-P) by 18F-PMPBB3 positron emission tomography (PET) imaging. Background: PSP is…Remote monitoring of physical activity in Progressive Supranuclear Palsy (PSP) using wearable sensors
Objective: To remotely monitor physical activity in people with PSP and to correlate it with disease progression on the modified PSP Rating Scale (mPSPRS-21). Background:…Quantification of Striatal and Extrastriatal Dopamine Transporters with [18F]PR04.MZ and [18F] PI- 2620 PET in Patients with Progressive Supranuclear Palsy.
Objective: We aim to evaluate the differences in striatal subregional dopamine transporter loss between Parkinson disease (PD) and progressive supranuclear palsy (PSP) of any stage…Expression profile of circRNA in peripheral blood mononuclear cells of patients with Parkinson’s disease and atypical parkinsonian syndromes
Objective: This study aimed to uncover circRNAs subsets with diagnostic potential for APS and iPD. Background: Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP)…
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 42
- Next Page »